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A B S T R A C T
This is the protocol for a review and there is no abstract. The objectives are as follows:
To synthesise Cochrane reviews of conservative interventions, as described above, for the prevention or treatment of female urinary
incontinence. Outcomes are described below.
B A C K G R O U N D
At least one-quarter of all adult women have urinary incontinence
(UI), with prevalence increasing with age (Sandvik 2000). Around
20% of women with urinary problems seek professional help;
this percentage increases with advancing age and is higher among
women with other concomitant urogenital problems (Morrill
2007).
Evidence suggests that for the majority of women affected, UI im-
pacts significantly on daily living. It has been shown to interfere
with physical, psychological and social activities of women, re-
ducing general health, wellbeing and quality of life (NICE 2013).
It is associated with an increased prevalence of major depression
(Melville 2009); and in older women is linked to social isolation
and psychological distress (Bogner 2002). UI can cause a number
of serious medical conditions, such as perineal rash, pressure ulcers
and urinary tract infections and increases the risk of admission to
long-term residential care (Hunskaar 2002). The annual cost to
the NHS of treating clinically significant female UI has been esti-
mated to be GBP 233 million (Perry 2000). This does not include
the personal costs borne by the women affected, which have been
estimated to be GBP 178 million (Turner 2004). UI is therefore
prevalent and costly to healthcare providers; and to women both
financially and in terms of physical and mental wellbeing.
Urinary incontinence can result from damage to the neural con-
trol of the bladder or the pelvic floor muscles, or from direct me-
chanical trauma to the pelvic floor (Glazener 2001). The risk is
increased by vaginal (particularly assisted) delivery, increasing age
and parity, obesity and the menopause (MacArthur 1993; Wilson
1996; Thom 1997). UI may also be caused by trauma or disease
to the bladder.
Incidence figures depend on the definition used and the popula-
tion investigated, with reported annual incidence rates (numbers
of new cases) of urinary incontinence ranging from 1% to 11%,
and the annual remission rate from 6% to 11% (Hunskaar 2005).
1Conservative interventions for urinary incontinence in women: an Overview of Cochrane systematic reviews (Protocol)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Description of the condition
Urinary incontinence (UI) is the involuntary loss of urine, and
can be caused by a number of different conditions (Blaivas 1997;
Haylen 2010).
Continence is achieved through an interplay of the normal
anatomical and physiological properties of the bladder, urethra,
sphincter and pelvic floor; and the nervous system co-ordinat-
ing these organs. The active relaxation of the bladder coupled by
the ability of the urethra and sphincter to contain urine within
the bladder by acting as a closure mechanism during filling, al-
low storage of urine until an appropriate time and place to void
is reached. The role of the pelvic floor in providing support to
the bladder and urethra, and allowing normal abdominal pressure
transmission to the proximal urethra is also considered essential in
the maintenance of continence. Crucial to the healthy function-
ing of the bladder, urethra, sphincter and pelvic floor is coordina-
tion between them, facilitated by an intact nervous system control.
Incontinence occurs when this normal relationship between the
lower urinary tract components is disrupted, resulting from nerve
damage or direct mechanical trauma to the pelvic organs. Advanc-
ing age, higher parity, vaginal delivery, obesity and menopause are
associated with an increase in risk (Rehman 2011).
There are three main types of UI:
1. Stress urinary incontinence (SUI): is the complaint of
involuntary loss of urine on effort or physical exertion (e.g.
sporting activities) (Haylen 2010). Stress UI is a symptom,
rather than a condition. Research has shown that about 50% of
the women below the age of 65 years with UI had stress UI
(Milsom 2012).
2. Urgency urinary incontinence (UUI): is the complaint of
involuntary loss of urine associated with urgency (Haylen 2010).
Isolated UUI is the least common type, accounting for 10% of
women who have UI (Milsom 2012).
3. Mixed urinary incontinence (MUI): is the complaint of
involuntary loss of urine associated with urgency and also with
effort or physical exertion or on sneezing or coughing (Haylen
2010). It occurs in around 30% of women (Milsom 2012).
In addition, loss of urine may occur:
• At night (nocturnal enuresis, the complaint of loss of urine
occurring during sleep) or the interruption of sleep because of
the need to urinate, with loss of urine if the toilet is not reached
in time to void); and
• During intercourse (coital incontinence, the complaint of
involuntary loss of urine with coitus, occurring with penetration
or intromission, or at orgasm)
Description of the interventions
A wide range of interventions can be delivered in an attempt to
reduce the symptoms of UI in women, including conservative,
pharmacological and surgical interventions. Conservative inter-
ventions are generally recommended as the first line of treatment
for women with UI (NICE 2013), and are therefore the focus
of this overview. However we will include reviews in which the
comparator intervention is a pharmacological, surgical or other
management intervention. We will include reviews in which a sin-
gle conservative intervention is delivered or in which two or more
conservative interventions are delivered in combination.
The type of intervention selected for an individual woman will
depend on an assessment of their symptoms, types of inconti-
nence, factors contributing to UI, associated medical conditions,
and clinician and individual choice.
Conservative interventions
Conservative management of UI largely comprises physical, be-
havioural and psychological interventions, often delivered in com-
bination (French 2010), including (but not limited to) (see Figure
1):
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Figure 1.
• Mechanical devices to prevent or reduce urinary leakage.
These include pessaries (urethral and vaginal inserts) and
mechanical plugs/patches (Lipp 2014).
• Physical therapies - for women with SUI the aim is to
improve muscle control. This principally includes pelvic floor
muscle training, which can be delivered with or without the use
of assistive devices such as weighted vaginal cones, biofeedback
or electrostimulation (Dumoulin 2014).
• Educational, behavioural and lifestyle advice to enhance
management of urinary incontinence. These commonly include
methods of toileting assistance, such as prompted voiding, habit/
bladder retraining and timed voiding (Eustice 2000;
Ostaszkiewicz 2004a; Ostaszkiewicz 2004b), and advice about
lifestyle factors, such as weight loss, management of fluid intake,
caffeine and alcohol intake and physical activity and exertion
(Imamura 2015).
• Psychological interventions. A range of psychological
therapies, based on a number of different philosophical or
theoretical approaches, can be used to help a woman cope with
her UI symptoms and improve her quality of life. These include
the Health Belief Model (Chiarelli 1999); Theory of Planned
Behaviour (Whitford 2011); and the Social Cognitive theory
(Self-efficacy) (Alewijnse 2003a; Alewijnse 2003b).
• Complementary therapies. The Complementary Medicine
Field of the Cochrane Collaboration defines complementary
medicine as “practices and ideas which are outside the domain of
conventional medicine in several countries” and which are
defined by its users as “preventing or treating illness, or
promoting health and wellbeing” (Smith 2006). Therapies which
are considered complementary practices in one country or
culture may be considered conventional in another. For the
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purpose of this overview, we define complementary therapies as
complementary interventions, such as acupuncture/
electroacupuncture, reflexology, but excluding medicines or
consumed remedies (i.e. excluding herbal medicines, traditional
Chinese medicines, homeopathic remedies) (Bø 2013).
In addition to these groups of interventions, there are a growing
number of digital health interventionswhich use new technologies
and media to support and enhance the delivery of conservative
management of UI. In particular, digital health interventions can
help support the delivery of behavioural-based interventions, and
may be used as part of bladder training or voiding programmes, or
both; (see How the interventions might work for further descrip-
tion of types of conservative interventions within these categories).
These conservative interventions are the focus of the Overview,
and the following interventions will only be included if they are
used as comparators in the included evidence.
Pharmacological (drug) interventions
A number of different pharmacological therapies have been inves-
tigated for the treatment of urinary incontinence, including
• oestrogen (Cody 2012)
• anticholinergic drugs (Rai 2012)
• adrenergic agents (Alhasso 2005) and
• botulinum toxin (Duthie 2011).
These interventions may have local or systemic effects.
Surgical interventions
Surgical procedures to remedy urinary incontinence generally aim
to lift and support the urethrovesical junction. It has been iden-
tified that there is disagreement about the precise mechanisms
achieved by surgery and that the choice of procedures is often in-
fluenced by a number of different factors, including co-existent
problems, a surgeon’s specialty and preference, and the physical
features of the person affected (Glazener 2001). Surgical methods
principally include
• open abdominal retropubic suspension (Lapitan 2016)
• laparoscopic retropubic suspension (Dean 2006)
• midurethral sling procedures (Ford 2015)
• traditional suburethral sling procedures (Rehman 2011)
• anterior vaginal repair (Glazener 2001)
• bladder neck needle suspensions (Glazener 2014)
• peri-urethral injections (Kirchin 2012)
• artificial sphincters (Islah 2013)
Other interventions for UI
In addition to these three groups of interventions, specialised prod-
ucts can be used in the management or treatment of UI.
These include special pads and bedsheets, as well as catheters,
sheaths and bags.
Investigation of UI
There are a number of different techniques for the diagnosis of
the cause of urinary incontinence, including urodynamic inves-
tigations (Clement 2013), diaries, pad tests (Groutz 2000), and
imaging techniques such as x-rays and ultrasound.
How the intervention might work
Conservative interventions can work in a variety of ways, and the
mechanism of action may be mechanical, physical, behavioural or
psychological, or a combination of these. For categories of conser-
vative interventions, see Figure 1.
Mechanical devices
These are physical devices that are designed to stop or control
urinary leakage. They can be inserted inside the vagina or urethra
(internal placement) or applied to the external surface of the ure-
thra (external placement) (Lipp 2014). These devices work in a
number of different mechanical ways:
• Intravaginal (or ’internal vaginal device’) (also known as
pessaries): These devices are inserted into the vagina with the
aim of supporting the bladder neck to improve stress urinary
incontinence (SUI). Some devices are also shaped with a knob
which compresses the urethra, which also helps to reduce SUI.
• Intra-urethral: This is a device that is inserted into the
urethra acting like a plug to prevent leakage. It is inserted and
removed by the individual as required.
• External urethral: This is a device that is applied like a seal
to the outer surface of the urethral opening (external placement)
to stop leakage of urine from the urethra.
Physical therapies
Physical therapies are provided by rehabilitation professionals, us-
ing specially designed exercises, delivered with or without the use
of assistive devices, to help individuals regain or improve physical
control of their bladder. These
• Pelvic floor muscle training involves repetitive selective
voluntary contraction and relaxation of specific pelvic floor
muscles. PFMT exercises can be taught to women by
rehabilitation professionals, but then are carried out
independently by the woman on a regular basis, with or without
supervision. PFMT can improve the strength, endurance and
coordination of these muscles (Alves 2015; Dumoulin 2014).
For those with UUI the biological rationale is based on Godec’s
observation that a detrusor muscle contraction can be inhibited
by a pelvic floor muscle contraction induced by electrical
stimulations (Godec 1975). Further de Groat 1997
demonstrated that during urine storage there is an increased
pudendal nerve outflow response to the external urethral
sphincter increasing intraurethral pressure and representing what
he termed a “guarding reflex” for incontinence (de Groat 1997;
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de Groat 2001). Additionally, Morrison 1995 demonstrated that
Barrington’s micturition centre excitatory loop switches on when
bladder pressures are between 5 to 25 mmHg, while the
inhibitory loop is predominantly active above 25 mmHg.
Inhibition involves an automatic (unconscious) increase in tone
for both the pelvic floor muscle and the urethral striated muscle.
Thus, voluntary pelvic floor muscle contractions may be used to
control UUI. After inhibiting the urgency to void and the
detrusor contraction, the woman can reach the toilet in time to
avoid urine leakage.
• Biofeedback is a technique used to supplement or enhance
PFMT. Information about a normally unconscious physiological
process is presented to the individual and the therapist as a
visual, auditory or tactile signal (Sandweiss 1985). Such feedback
enables a person to identify and modify a bodily function of
which they may be unaware. Typically this may involve digital
palpation or the use of a device to record the biological signals
(e.g. squeeze pressure, electrical activity, pelvic floor
morphometry using ultrasound) during a voluntary pelvic floor
muscle contraction and presentation of this information back to
the woman in auditory or visual form. Examples of this feedback
are verbal encouragement, a louder sound with a stronger
squeeze or an increasing number of lights on a visual display as
the strength of the squeeze increases, and visual display of levator
ani contraction on an ultrasound screen. Thus for a muscle that
cannot be seen, unlike for example the quadriceps muscles of the
knee, the women receives some sort of signal about their ability
to use their pelvic floor muscle. Biofeedback may also be
provided by the use of weighted vaginal cones, which are small
weights placed in the vagina which require contraction of the
pelvic floor muscle to prevent them from slipping out. The cones
provide a form of biofeedback as the sensation of one slipping
out induces a pelvic floor muscle contraction which may both
strengthen muscles and help to synchronize muscle contraction
with increases in abdominal pressure (Herbison 2013)
• Stimulation A number of different types of stimulation,
including electrical and magnetic stimulation, can be delivered
through either surface electrodes (transcutaneous) or via direct
stimulation (percutaneous) with the aim of stimulating the nerve
supply and altering nerve activity. Stimulation of nerve supply is
thought to improve muscle tone and sensation of the pelvic floor
muscles, enhancing muscle control; and it also aims to reduce
detrusor contraction in the case of UUI. Electrical stimulation
therapy can be used to treat overactive bladder via different
routes, such as implantable or internal electrodes (sacral
neuromodulation) and non-implantable or external electrodes.
The latter can be sub-classified as endocavitary electrodes (rectal
or intravaginal) or percutaneous electrodes (tibial nerve
stimulation). Cadwell 1963 was the first to report the use of
intravaginal electrical stimulation (IES) in the treatment of
urinary incontinence. Subsequently, Messelink 1999 also used it
with satisfactory results. IES using frequencies below 12 Hz
stimulates the pudendal nerve, which may inhibit the detrusor
muscle, reduce involuntary contractions and, consequently,
reduce the number of micturitions in 24 hours (Messelink
1999). Electrical stimulation also works in a passive way, helping
women to become conscious of the perineal muscle contraction
and this may, in turn, help to inhibit detrusor involuntary
contractions (Amaro 2003). IES can be used on its own or in
association with pelvic floor muscle exercises, often indicated in
SUI and OAB. Percutaneous tibial nerve stimulation (PTNS) is a
form of neuromodulation that delivers retrograde stimulation to
the sacral nerve plexus through percutaneous electrical
stimulation of the posterior tibial nerve via a needle electrode
inserted cephalad to the medial malleolus, an anatomical area
recognized as the bladder centre (Hajebrahimi 2015).
• Magnetic stimulation appears to induce inhibitory effects
on detrusor overactivity in a similar manner to electrical
stimulation, with the significant clinical advantage of being non-
invasive (Takahashi 2003).
• Bladder training encourages people to extend the time
between voiding so that continence might be regained. This can
take months to achieve but may help people who are physically
and mentally able to use this method. For those with UUI the
biological rationale is based on Godec’s observation that a
detrusor muscle contraction can be inhibited by a pelvic floor
muscle contraction induced by electrical stimulation (Godec
1975). Further de Groat 1997 demonstrated that during urine
storage there is an increased pudendal nerve outflow response to
the external urethral sphincter increasing intraurethral pressure
and representing what he termed a “guarding reflex” for
incontinence (de Groat 1997; de Groat 2001). Additionally,
Morrison 1995 demonstrated that Barrington’s micturition
centre excitatory loop switches on when bladder pressures are
between 5 to 25 mmHg, while the inhibitory loop is
predominantly active above 25 mmHg. Inhibition involves an
automatic (unconscious) increase in tone for both the pelvic
floor muscle and the urethral striated muscle. Thus, voluntary
pelvic floor muscle contractions may be used to control UUI.
After inhibiting the urgency to void and the detrusor
contraction, the woman can reach the toilet in time to avoid
urine leakage (Wallace 2004)
• Manual therapy is defined as a clinical physical approach
utilizing specific hands-on techniques. It may include massage,
soft tissue mobilization, various connective tissue techniques,
myofascial release, mobilization of joints, joint manipulation or
mobilization of nerve tissue. It is used to diagnose and treat soft
tissues and joint structures for the purpose of modulating pain;
increasing range of motion; reducing soft tissue oedema;
inducing relaxation; improving contractile and non-contractile
tissue extensibility, and/or stability; facilitating movement; and
improving function (Personal Communication: Bø 2016).
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In addition to these groups of interventions, there are a growing
number of digital health interventions which use new technolo-
gies andmedia to support and enhance the delivery of conservative
management of UI. In particular, digital health interventions can
help support the delivery of behavioural-based interventions, and
may be used as part of bladder training or voiding programmes.
Educational, behavioural and lifestyle advice
Several lifestyle factors are thought to play a role either in the onset
or later in the resolution or management of UI. These include:
• Diet: many dietary factors are thought to aggravate urinary
urgency, and may also relate to weight gain or constipation, or
both (see below). Dietary advice can therefore be beneficial to
the management of UI (Imamura 2015).
• Exercise and activities of daily living (ADL) advice:
weakened pelvic floor support structures and raised intra-
abdominal pressure caused by heavy lifting and strenuous
activity may result in UI. Strenuous activity alone may also
increase incontinence in the short term. Appropriate advice can
help women to manage the impact of exercise and daily physical
activity on UI, whilst maintaining a healthy lifestyle (Bø 2013).
• Fluid/caffeine intake: worsening of urinary urgency,
frequency and incontinence is often reported after consuming
caffeine, alcohol, fizzy drinks, sweetened diet drinks or excessive
fluids. Caffeine can increase bladder muscle contractility,
whereas alcohol or excessive fluids may have a diuretic effect
(Imamura 2015) .
• Voiding interventions: this is a broad term which is used
to describe any type of scheduled toileting intervention, which
can include programmes of scheduled bladder voiding and
bladder training (aimed at trying to correct faulty habit patterns
of frequent urination (if present), improve control over bladder
urgency, prolong voiding intervals, increase bladder capacity,
reduce incontinent episodes, and restore women’s confidence in
controlling bladder function) (Eustice 2000).
• Weight loss/obesity: obesity and urinary incontinence are
common problems in women. Obese women have higher intra-
abdominal pressure than non-obese women, and it is thought
that this chronically elevated pressure may predispose to
incontinence in two ways: firstly by weakening pelvic floor
support structures; and secondly by raising the intra-abdominal
pressure (Imamura 2015) .
• Smoking cessation: there is evidence of a relationship
between cigarette smoking and UI, although the mechanism is
not fully understood (Bump 1992). Chronic coughing among
smokers may also contribute to UI by raising intra-abdominal
pressure (Imamura 2015) .
• Healthy bowel management: constipation can obstruct
the bladder, preventing adequate voiding and resulting in urine
leakage. Chronic straining may also be a risk factor in the
development of UI. Advice which avoids or limits constipation or
chronic straining may improve or prevent UI (Imamura 2015) .
• Anatomy and physiology education: educational
interventions to teach women about the causes of their UI may
improve understanding of the condition and may therefore help
women manage their symptoms (Imamura 2015) .
Psychological therapies
There are many different types of psychological therapies, which
are based on a range of theoretical and philosophical standpoints.
These are often forms of talking therapy, with individuals or in
groups, butmay also include interventions such as telephone or in-
ternet-based support. Psychological therapies are generally aimed
at helping people change the way they think and behave. Psy-
chological therapies may help women with UI to manage and
maintain a sense of wellbeing and enhance quality of life. For the
purposes of this overview we will consider psychological therapies
within the categories proposed and described by Shinohara 2013,
as follows:
• Behavioural therapies: this includes behavioural therapy,
behavioural activation, social skills training/assertiveness
training, and relaxation therapy.
• Cognitive-behavioural therapies: this includes cognitive
therapy, rational emotive behavioural therapy, problem-solving
therapy, self-control therapy, and courses aimed at coping with
depression.
• Mindfulness-based ‘third wave’ cognitive and
behavioural therapies: this includes acceptance and
commitment therapy, compassionate mind training, functional
analytical psychotherapy, extended behavioural activation, meta-
cognitive therapy, mindfulness-based cognitive therapy, and
dialectical behavioural therapy.
• Psychodynamic therapies: this includes interventions
based on Drive/structural model, Relational model, and
Integrative analytical model.
• Humanist therapies: this includes Person-centred therapy,
Gestalt therapy, experiential therapies, transactional analysis,
existential therapy, and non-directive/supportive therapies.
• Interpersonal, cognitive analytic and other integrative
therapies: this includes interpersonal therapy, cognitive-analytic
therapy, psychodynamic-interpersonal therapy, cognitive-
behavioural analysis system of psychotherapy, counselling, and
motivational interviewing.
Complementary therapies
A number of different alternative therapies, such as hypnotherapy
and acupuncture, may be used, often alongside other conservative
interventions. These interventions are generally provided to help
people feel better and to promote health and wellbeing. Comple-
mentary therapies used to reduce symptoms and promote wellbe-
ing in women with UI may include (but are not limited to):
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• Acupuncture/Electroacupuncture: this is the practice of
inserting a needle or needles into certain points in the body for
therapeutic purposes (Wang 2013).
• Hypnotherapy: this is a form of psychotherapy that can be
used to create subconscious change in an individual in the form
of new responses, thoughts, attitudes, behaviours or feelings
(Komesu 2011).
• Bowen Technique: this is a hands-on therapy in which very
gentle pressure is applied to specific points on the body (Wilks
2007) .
• Reflexology: is a massage used to relieve tension and treat
illness, based on the theory that there are reflex points on the feet,
hands, and head linked to every part of the body (Yau 2006).
Other conservative interventions
There are a number of other conservative interventions whichmay
be used for women with UI, which do not fit within the above
categories. These can include (but are not limited to):
• Core-stability training: specific exercises, comprising
stretching and strengthening exercises which are adapted to the
condition of the intervention, aimed at improving muscle
strength and control around the pelvic area. These exercises may
be delivered by an exercise instructor or person who is not a
rehabilitation professional. Increased muscle strength and
control around the pelvic area may improve the symptoms of UI
by changing intra-abdominal pressure and increasing pelvic floor
muscle control (Bø 2013).
• Breathing exercises/Hypopressive exercise: breathing
exercises generally aim to complement PFMT by changing the
pressure on the abdominal wall and improving the overall quality
of pelvic floor muscle training exercises (Bø 2013).
• Pilates: modern Pilates exercise programmes incorporate
exercises that involve breathing and contraction of pelvic floor
muscles. The pelvic floor muscles are not specifically trained, but
pelvic floor muscles are trained incidentally during exercise and
movement. The co-contraction of pelvic floor muscles that
occurs incidentally during Pilates exercises will counteract
increases in intra-abdominal pressure that occur during exercise,
preventing leakage and strengthening pelvic floor muscles (Bø
2013).
• Yoga: a physical, mental and spiritual practice, which may
benefit UI through changes to physical (e.g. muscle stretching,
control) and psychological mechanisms (Bø 2013).
• Paula Method: all sphincters in the body work
simultaneously so exercising the ring muscles of the mouth, eyes,
or nose may result in co-contraction and strengthening of the
pelvic floor muscles (Bø 2013).
• Tai Chi: Tai Chi is an ancient exercise regimen originating
in China and has widespread use as exercise for general health in
China. Chang 1986 describes an exercise called
• ‘the deer’ involving contraction of the anal sphincter. The
exercise is recommended for both men and women for
conditions related to the pelvic area (Bø 2013).
• Posture: Theory: Carriere 2006 has claimed that “poor
posture” can lead to pain and dysfunction in the pelvic floor. It is
thought that optimal strategies for transferring loads will balance
control of movement while maintaining optimal joint axes,
maintain sufficient intra-abdominal pressure without
compromising the organs (preserve continence, prevent prolapse
or herniation) and support respiration. Non-optimal strategies
for posture, movement and breathing, or combinations thereof,
create failed load transfer which can lead to pain, incontinence
and breathing disorders (Bø 2013).
Why it is important to do this overview
Conservative management is recommended as a first line of treat-
ment for women with UI (NICE 2013). They often have complex
aetiologies and co-morbid conditions and identifying the most ef-
fective rehabilitation interventions is not always easy. Given the
importance of curing, improving or managing UI symptoms to
allow women to have an active lifestyle and good quality of life,
there are a substantive and growing number of randomised con-
trolled trials (RCTs) and systematic reviews relating to the effec-
tiveness of conservative interventions for UI. Despite this growing
body of evidence, current clinical practice often does not reflect the
available increasing evidence-base. This important area of prac-
tice receives little attention in undergraduate physiotherapy edu-
cation, for example, less than 2 hours in the UK (McClurg 2013),
and is largely driven by post-graduate courses and peer support
in Canada (Francis 2012). Lack of sufficient time to identify and
synthesise evidence is cited as the key barrier to evidence-utilisa-
tion within UI rehabilitation (McClurg 2013).
It has been recognised that a large and growing body of systematic
reviews can be overwhelming for decision makers, and health-care
practitioners do not have time to keep up to date with this ev-
idence-base (Bastian 2010). The Cochrane Incontinence Group
has (in December 2015) 107 reviews and protocols relating to uri-
nary incontinence, of which 55 are related to mechanical, physi-
cal, psychological or educational interventions for the treatment
or prevention of urinary incontinence (CIG 2015). This large
number of Cochrane reviews may be overwhelming for healthcare
practitioners seeking best evidence relating to conservative inter-
ventions for urinary incontinence, and create a barrier to evidence-
based practice. It is therefore important to bring all Cochrane
reviews relating to conservative interventions for the prevention
or treatment of female urinary incontinence together, in order to
signpost clinical decision makers to best evidence and support ef-
ficient use of best evidence.
Furthermore, while Cochrane reviews synthesise available RCT
evidence relating to UI in women, these Cochrane reviews often
explore the effects of specific single interventions compared to
placebo or control interventions. However, in clinical practice, the
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choice will be generally be between a variety of interventions (or
a combination) rather than an all-or-nothing choice of using or
not using one of the interventions. Thus the synthesis of evidence
relating to single, specific UI interventions fails to facilitate trans-
lation of evidence into clinical practice or decision making.
A Cochrane overview of conservative interventions for women
with UI will synthesise into one accessible, comprehensive doc-
ument all high quality evidence about UI conservative interven-
tions, assess the limitations of current best evidence and enable
indirect comparisons of the effects of different interventions on
UI. This proposed overview will support evidence-based manage-
ment ofUI amongst key decisionmakers (such as clinicians, policy
makers, or informed health service users) and educators of Allied
Health Professionals.
O B J E C T I V E S
To synthesise Cochrane reviews of conservative interventions, as
described above, for the prevention or treatment of female urinary
incontinence. Outcomes are described below.
M E T H O D S
Criteria for considering reviews for inclusion
We will include any Cochrane review that meets the following
criteria:
Participants: Reviews of studies in which the participants are fe-
male adults (≥ 18 years) with a clinical diagnosis of UI, regardless
of cause or comorbidities, and including stress, urge or mixed UI.
Interventions: Reviews of studies which investigate a conservative
intervention for which the primary aim is to prevent, improve or
cure UI. Conservative interventions include those listed in How
the interventions might work, and are illustrated in Figure 1.
As long as the above inclusion criteria are met, we will include
reviews of trials in which the participants:
• have other, co-morbid, health-related problems including
(but not limited to): pregnancy and delivery, cancer, neurological
diseases, chronic respiratory disease, learning difficulties and
dementia.
• can be recruited from any setting, including community,
hospital or care home environments.
We will consider reviews which include both male and female
participants, but will only include reviews in which we can extract
data relating specifically to the female participants.
We will exclude reviews of surgical or pharmacological interven-
tions, products to manage leakage of urine and investigative tech-
niques, unless these are compared with a conservative interven-
tion. We will include reviews in which a conservative intervention
is considered to be a control intervention.
Search methods for identification of reviews
Relevant reviews will be identified from the Cochrane Inconti-
nence Review Group’s list of published Cochrane reviews. We will
also search the Cochrane Database of Systematic Reviews (part
of The Cochrane Library) using the strategy given in Appendix 1.
Titles and protocols registered with the Cochrane Incontinence
Review Group will also be considered.
Data collection and analysis
During the process of data collection and analysis, evidence relat-
ing to stress, urgency or mixed UI will be separated, and will be
subgrouped according to these three separate groups.
The aim of this stage of the overview is on systematically bringing
together assessment of methodological quality and presentation of
data from the included reviews. With the exception of the final
section, ’Data analysis’, description of methods within subsequent
sections will therefore refer to synthesis of data as presented within
the included reviews, and not to any re-analysis or pooling of data.
Selection of reviews
Two independent reviewers will consider titles and abstracts from
the identified reviews and apply the inclusion criteria (see Criteria
for considering reviews for inclusion). If there is disagreement be-
tween reviewers, they will reach consensus through consideration
and discussion of the full paper, involving a third reviewer if nec-
essary.
We will contact authors of any titles or protocols which appear
to meet our selection criteria, identifying those which authors
indicate should be completedwithin 3months of our initial search
date.Wewill also contact authors of all completed reviewsmeeting
our selection criteria for which the search date is more than 12
months ago, asking if an update is anticipated within this 3-month
period. Initial contact with review authors will be made via the
Cochrane Incontinence Review Group. When authors indicate
that a review should be finished/updated within this timeframe,
we will send reminder emails in advance of this date to check on
progress, and to gain access to relevant pre-publication data where
possible.
Data extraction and management
Two overview authors will extract data independently. Disagree-
ments will be resolved by discussion, with assistance from a third
overview author if necessary. We will use a data collection form
specifically designed and piloted by the overview author team.
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Onto this form, we will extract and record key features of each
review including details of the aims and rationale, types of studies,
participants, interventions, comparisons, outcomes assessed, date
of last search and meta-analyses completed.
We will systematically synthesise, using a spreadsheet, the studies
included within all identified reviews to explore whether any re-
views covered the same studies. When overlap between reviews is
identified, two overview authors will discuss the overlap with con-
sideration of each review question and comparisons explored, the
date of the last search and key aspects of methodological quality
(e.g. types of studies included, risk of bias assessment). We will use
these details to reach agreement regarding which data from which
review comparisons should be included within the overview.
Type of UI
During this phase of data extraction two independent reviewers
will note whether each included review includes evidence relating
to stress, urgency or mixed UI, or a combination thereof. We
will resolve any disagreements through discussion, using a third
reviewer if necessary. We will compile a list of which reviews relate
to each of these three types of UI. All subsequent stages of the
overview will be completed in triplicate, for:
• Conservative interventions for management of stress UI
• Conservative interventions for management of urgency UI
• Conservative interventions for management of mixed UI
We anticipate that some reviews may include populations with
more than one type of UI. If separate data are available for pop-
ulations with different types of UI then we will include the rele-
vant data within the synthesis relating to stress/urgency/mixed UI.
Thus one review may be included in more than one of the above
groups. If a review only contains data relating to a combined pop-
ulation, and separate data are not available, then we will include
this review within a fourth section:
• Conservative interventions for management of stress,
urgency or mixed UI (combined populations)
• Unclear as some reviews do not define populations
Criteria for identifying relevant comparisons
We will use extracted data to determine which reviews have meta-
analyses (comparisons) of relevance to this overview according
to the three populations of women with UI (SUI, UUI, MUI).
Relevant comparisonswill evaluate the effect on the stated primary
or secondary outcomes of interest to the overview by comparing
the effects of:
1. Any conservative intervention versus control, placebo or
standard care
2. Any conservative intervention versus other active
intervention (i.e. surgical or pharmacological intervention)
3. One conservative intervention versus another conservative
intervention
4. Comparisons of different doses, intensities or timing of
delivery of conservative intervention
Primary Outcomes
The primary outcomes of interest to this overview are:
1. Condition-specific quality of life, as measured by specific
instruments designed to assess the impact of UI symptoms on
the life of a women, such as King’s Health Questionnaire
(Kelleher 1997), Incontinence Quality of Life (I-QOL) (Wagner
1996) and Bristol Female Lower Urinary Tract Symptoms (B-
FLUTS) questionnaire (Jackson 1996)
2. Symptomatic cure or improvement of UI, as reported by
the woman (including through self-report or bladder diaries)
Secondary Outcomes
1. Participant-reported cure only, accepting the definition of
cure used in the review. .
2. General quality-of-life measures (i.e. not condition-
specific), such as Short Form-36
3. Adverse effects (e.g. discomfort, soreness, pain, bleeding)
4. Measures of anxiety/depression, such as Hospital Anxiety
and Depression Scale (HADS)
5. Other clinician-measured or observed outcomes (e.g. pad
tests, pad weights, frequency of UI). (Note: even if reported as
’cure/improvement’, clinician-based measures will be considered
secondary outcomes)
6. Other participant self-report not presented as cure or
improvement
7. Pelvic floor muscle strength/function (e.g. digital
evaluation, pelvic floor muscle dynamometry or
electromyography, vaginal squeeze pressure, perineal ultrasound)
8. Skin integrity
9. Adherence to intervention (including measures of usability/
acceptability)
10. Urodynamics (urodynamic testing) (e.g. post-void residual
volume, rate of bladder emptying, detrusor pressure)
11. Socioeconomic measures (e.g. cost of intervention,
economic analysis, resource implications)
12. Other
We will consider outcomes at three time periods:
1. The end of treatment
2. Up to one year after end of treatment
3. More than one year after end of treatment.
We will categorise outcomes pooled within meta-analyses as either
’immediate’ (i.e. at the end of intervention) or ’follow-up’, doc-
umenting and reporting within tables the timepoint of the data
pooled, as reported in the included review.
We will identify information relating to all outcomes synthesised
within the included reviews, but will only extract data relating to
effect size from relevant meta-analyses of comparisons relating to
these stated outcomes of interest.
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Data extraction for relevant comparisons
Data extracted relating to meta-analyses will include:
1. The number of trials and participants
2. The mean difference or standardised mean difference (for
continuous data)
3. The risk ratio or risk difference (for binary data), with 95%
confidence intervals
4. The I² statistic for heterogeneity
Where meta-analyses include presentation of subgroup data these
will also be documented. These data will be checked by a second
overview author with reference to the published review.
Assessment of methodological quality of included
reviews
For each relevant comparison reported in each included review,
one overview author will systematically extract data on the risk
of bias (as documented in the published review; ideally using the
Cochrane ’Risk of bias’ tool, Higgins 2011b) relating to trials
within each comparison and the results of the meta-analyses per-
formed.
Quality of included reviews
Two independent overview authors will assess the methodological
quality of the included reviews using the ROBIS (Risk Of Bias In
Systematic reviews) tool (Whiting 2015). ROBIS is completed in
three phases: (1) Assess relevance; (2) identify concerns with the
review process; and (3) judge risk of bias in the review. The second
phase will include assessment of whether
• review eligibility criteria were clear, appropriate and pre-
specified;
• all relevant primary studies should have been identified and
included in the review;
• bias may have been introduced through the data collection
or risk of bias assessment processes;
• appropriate methods have been used for any meta-analyses.
All signalling questions, which are included within the ROBIS
tool to help assess specific concerns about potential biases within
the review, will be completed and used to help overview authors
judge overall risk of bias. We will use the rating guidance pub-
lished with the ROBIS tool in answering all signalling questions
(Whiting 2015). We will judge the risk of bias of each review to
be at low, high or unclear risk of bias. We will resolve any disagree-
ments between independent overview authors through discussion,
involving a third reviewer if necessary.
If any overview authors are authors on an included review, they
will not be involved in the assessment of methodological quality
of that review, and this will be done independently by two other
overview authors.
The agreed responses to all ROBIS phases and judgement will be
tabulated and fully reported within the overview.
Quality of evidence in included reviews
We will not reassess the quality of individual studies included
within reviews but will report the quality of individual studies
according to the review authors’ assessment.
We will assess the quality of the evidence synthesised within each
relevant comparison (i.e. all relevant meta-analyses from included
reviews which pool data for one of our pre-stated primary or
secondary outcomes of interest) using the GRADE (Grading of
Recommendations Assessment, Development and Evaluation) ap-
proach (Guyatt 2008; Guyatt 2011a), which includes the follow-
ing:
• Risk of bias due to flawed design or conduct of studies
(Guyatt 2011b).
• Imprecision (e.g. when confidence intervals for treatment
effect are wide) (Guyatt 2011d).
• Inconsistency (e.g. when point estimates vary widely, I² is
large) (Guyatt 2011e).
• Indirectness (e.g. variations in participants, interventions,
comparisons and outcomes) (Guyatt 2011f).
• Publication bias (may be explored with the use of funnel
plots and classed as ’not suspected’, ’suspected’, ’strongly
suspected’ or ’very strongly suspected’) (Guyatt 2011c).
The GRADE approach provides a system for rating quality of
evidence and strength of recommendations that is explicit, com-
prehensive, transparent, and pragmatic and is increasingly be-
ing adopted by organisations worldwide. However, difficulties as-
sociated with the subjectivity involved in judging grade of evi-
dence has previously been reported, and poor agreement has been
found on grading strength of evidence within systematic reviews
using GRADE, even amongst experienced systematic reviewers
(Berkman 2013). A previous Cochrane overview has reported
that it was difficult to achieve agreement between independent
overview authors for GRADE judgements when a large number of
comparisons needed to be assessed (Pollock 2014), and proposed
the use of an objective algorithm to enable transparent, repro-
ducible assignment of GRADE levels of evidence (Pollock 2014;
Pollock 2015).
The overview author teamwill therefore explore use of the iterative
methods reported by Pollock 2015 to develop a set of objective
criteria for exploring the quality of the specific body of evidence
included within this overview. A consecutive sample of five reviews
will be used to explore and develop a final algorithm, involving
comparison of the subjective grading of evidence applied by three
independent overview authors, with data generated using a draft
algorithm. The draft algorithm will involve systematic assessment
of:
• the number of participants within the analysis;
• the risk of bias of trials contributing participants to the
analysis, as reported by the review authors within ’Risk of bias’
tables;
• heterogeneity within the analysis, as determined by I²; and
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• the methodological quality of the review, as determined by
our ROBIS assessment.
However the iterative, exploratory process used to develop the
final algorithm may lead to the addition or removal of criteria
(using themethods described by Pollock 2015).Wewill document
this process and detail the final objective algorithm. We will be
guided by key publications relating to application of the GRADE
framework (Guyatt 2011a).
Following agreement of the final algorithm, two overview authors
will work together to ensure consensus and consistency of entry of
objective data pertaining to these criteria onto a spreadsheet, and
will apply the objective algorithm to determine whether evidence
arising from each comparison relating to one of our pre-stated
outcomes of interest was classed as ’high’, ’moderate’, ’low’ or ’very
low’ within GRADE, based on the following definitions (Balshem
2011).
• High quality: We are very confident that the true effect lies
close to that of the estimate of the effect.
• Moderate quality: We are moderately confident in the effect
estimate: The true effect is likely to be close to the estimate of the
effect, but there is a possibility that it is substantially different.
• Low quality: Our confidence in the effect estimate is
limited: The true effect may be substantially different from the
estimate of the effect.
• Very low quality: We have very little confidence in the effect
estimate: The true effect is likely to be substantially different
from the estimate of effect.
Data synthesis
As stated above, all data synthesis will be grouped and presented
according to the type of UI: 1. stress, 2. urgency, 3. mixed, 4.
combined populations, 5. unclear.
We will tabulate a summary of systematic review evidence relating
to all conservative interventions for UI, clearly signposting which
systematic reviews address which interventions, with summary of
details of the population of participants, comparisons, volume
and quality of evidence. We will categorise the conservative inter-
ventions using the categories described in How the interventions
might work and Figure 1. Where conservative interventions are
delivered in combination we will categorise these according to the
combined interventions, but clearly highlighting the individual
interventions.
For each relevant intervention comparison and for both pri-
mary and secondary outcome of interest (see Data extraction and
management) we will produce a ’Summary of results’ table (see
Table 1) clearly indicating where there is evidence of an effect of
conservative interventions. In addition to this summary we will
tabulate - for both primary and secondary outcomes - the number
of studies and participants included in the comparison, the mean
difference or standardised mean difference (for continuous data),
the risk ratio or risk difference (for binary data), 95% confidence
intervals, and the I² statistic for heterogeneity.Wewill clearly high-
light where the data indicate statistically significant evidence of
benefit, harm or no effect, relating this to the assigned GRADE
quality of evidence.
Exploration of subgroups
The objective of this overview is to systematically synthesise the
results of data pooled within reviews relating to conservative in-
terventions for different types of urinary incontinence. As part of
this objective we plan to explore existing data relating to different
subgroups of women. We do not plan to carry out any statisti-
cal subgroup comparisons ourselves. Where the included reviews
have carried out subgroup analyses relating to our pre-defined sub-
groups (listed below), using data from one of our primary out-
comes, we will extract and tabulate the results of these analyses.
We will report the pooled data for all the subgroups as defined
within the included reviews, and the results of the statistical test
for subgroup differences.
Where possible we will synthesise data from meta-analyses of our
stated primary outcomeswhich relates to the followingpre-defined
subgroups:
1. Severity of symptoms (mild/moderate/severe)
2. Pregnancy (pregnancy/no pregnancy, and antenatal/
postnatal and mode of delivery)
3. Health-related cause of UI (cancer, neurological diseases,
chronic respiratory disease, learning difficulties, dementia)
4. Age (pre-menopausal/post-menopausal)
5. Co-morbidities (i.e. any other conditions)
6. BMI (normal/obese/morbidly obese)
7. Ethnicity
8. Duration of symptoms
9. Place of living (living at home, in care home or in nursing
home)
10. Socio-economic status.
In addition, where possible we will synthesise data relating to
groups of participants with nocturia, nocturnal enuresis and coital
incontinence. Data relating to any of these subgroups will be tab-
ulated, grouped according to intervention.
Statistical analysis
Themain aim of this overview is to provide a summary of evidence
relating to the effectiveness of conservative interventions for UI.
Descriptive summaries of the data relating to comparisons with
the included reviews will be reported.
For our three populations of interest (stress UI, urgency UI, mixed
UI), and for our primary outcomes of (1) condition-specific qual-
ity of life and (2) symptomatic cure or improvement of UI, we
will also:
1. Summarise the available data by creating a visual map of the di-
rect comparisons reported by the individual trials included within
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the reviews. These network maps will illustrate the number of tri-
als and number of participants within trials. Networkmaps will be
created using Stata software. The mapping function available al-
lows for weighting and colouring options for both nodes and edges
in the map, which reveal important differences in the characteris-
tics of treatments or comparisons (Chaimani 2013; Palmer 2016).
For example, the nodes and edges can be weighted according to
the number of studies or participants involved in each treatment
and comparison respectively. These summaries will illustrate the
quantity and quality of evidence for different comparisons, but
are not designed to summarise effect sizes for the comparisons.
2. Perform subgroup analyses, for comparisons of intervention ver-
sus control, placebo or standard care. Subgroup analyses will only
be completed following an exploration of the clinical populations
included in the trials in the included reviews. Three overview au-
thors, including a content expert, methods expert and statistician,
will discuss the available data and reach consensus on whether
any data are suitable for meta-analysis. The authors will consider
whether the enrolment criteria to the trials of different interven-
tions, contained within different reviews, are similar in relation
to etiological factors, symptom severity, comorbidities and other
relevant factors. The outcome of these discussions will be docu-
mented and reported to ensure transparency of this decision mak-
ing. Where the clinical populations of trials included in reviews of
different interventions are judged to be similar we will estimate the
difference between the subgroups and determine its statistical sig-
nificance (Higgins 2011a). The difference between the summary
effects in any two given subgroups will provide an estimate of the
indirect comparison of different interventions (Higgins 2011b).
If possible, we will complete the following subgroup analyses, for
populations of women with stress UI, urgency UI and mixed UI:
a) Any conservative intervention versus control, placebo or stan-
dard care for condition-specific quality of life, with subgroups de-
fined according to type of intervention. Continuous data (means,
standard deviations, number of participants) relating to the effects
reported by individual trials and included in relevant reviews will
be extracted and entered into a subgroup analysis within Review
Manager 5 or Stata, and depicted with forest plots. We will com-
pute standardised mean differences for the different subgroups,
pooling data from different condition-specific quality of life mea-
surement scales. We will report the test for subgroup differences
using an inverse-variance random-effects model for meta-analysis
of continuous outcomes (Deeks 2011).
b) Any conservative intervention versus control, placebo or stan-
dard care for symptomatic cure or improvement of UI, with sub-
groups defined according to type of intervention. Binary counts
data (number of events, number of participants) relating to the
events reported by individual trials and included in relevant re-
views will be extracted and entered into a subgroup analysis within
ReviewManager 5 or Stata, and depicted with forest plots. We will
compute the relative risk for the different subgroups, and report
the test for subgroup differences using the generic inverse-variance
random-effects model (Deeks 2011).
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A D D I T I O N A L T A B L E S
Table 1. Summary of results
Important difference Small difference (may not be
important)
Little or no difference
High certainty evidence INTERVENTIONS
(insert list) which improve/de-
crease/prevents OUTCOME
INTERVENTIONS (insert
list) which improves slightly/de-
creases slightly OUTCOME
INTERVENTIONS (insert
list) which results in little or no
difference in OUTCOME
Moderate certainty evidence INTERVEN-
TIONS (insert list) which prob-
ably improve/decrease/prevents
OUTCOME
INTERVEN-
TIONS (insert list) which prob-
ably improves slightly/decreases
slightly OUTCOME
INTERVENTIONS
(insert list) which probably re-
sults in little or no difference in
OUTCOME
Low certainty evidence INTERVENTIONS
(insert list) whichmay improve/
decrease/prevents OUTCOME
INTERVENTIONS
(insert list) which may improve
slightly/decrease slightly OUT-
COME
INTERVENTIONS (insert
list) which may result in little or
no difference in OUTCOME
Very low certainty evidence It is uncertain whether INTERVENTIONS (insert list) improves/decreases/prevents OUTCOME
because the certainty of the evidence is low
No data or no studies OUTCOME was not measured or not reported or no studies were found that evaluated the impact
of INTERVENTION on OUTCOME
Draft summary of results table. Separate summary of results tables are planned for each of the stated primary and secondary outcomes
of interest to this overview.
(Table adapted from presentation by A Oxman at Cochane Meeting, Athens, May 2015).
A P P E N D I C E S
Appendix 1. Cochrane Database of Systematic Reviews search strategy
[this strategy will be finalised once this approach has been OKed by CEU]
The Cochrane Database of Systematic Reviews will be searched from inception to the most recent issue using the following search
strategy:
#1 incontinen*:ti,ab,kw (Word variations have been searched)
#2 continen*:ti,ab,kw (Word variations have been searched)
#3 MeSH descriptor: [Urinary Bladder, Overactive] explode all trees
#4 MeSH descriptor: [Urinary Bladder, Neurogenic] explode all trees
#5 MeSH descriptor: [Urinary Incontinence] explode all trees
#6 ((bladder or detrusor or vesic*) near/2 (hyper* or overactiv*)) .ti,ab,kw.
#7 urin* near/2 (leak* or freq* or urge*) .ti,ab,kw.
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#8 ((bladder or detrusor or vesic*) near/5 (instab* or stab* or unstab* or irritab* or hyperreflexi* or dys*ynerg* or dyskinesi* or irritat*))
.ti,ab,kw.
#9 (bladder$ near/2 (neuropath* or neurogen* or neurolog*)) .ti,ab,kw.
#10 (pollakisur* or pollakiur*) .ti,ab,kw.
#11 #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10
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